Of note, cancer cells producing EVs devoid of PD-L1 were recently reported to facilitate tumor growth inhibition in vivo even when the tumors were able to express cell-surface PD-L1.20 Taken together, these data support the further study of Sigma1 inhibitors in modulating immune cell infiltration in in vivo models of cancer. Here, CD274 is linked to cancer.